INIS
coronaviruses
100%
belgium
70%
saliva
50%
france
50%
sensitivity
50%
universities
50%
surveys
50%
accuracy
50%
sampling
50%
communities
50%
testing
50%
quality assurance
50%
laboratories
50%
performance
12%
females
12%
europe
12%
drugs
12%
concentration
12%
lifetime
12%
quality management
10%
capacity
10%
covid-19
10%
pathogens
10%
demand
10%
diseases
10%
public health
10%
patients
9%
comparative evaluations
9%
personnel
8%
Keyphrases
High Sample Throughput
50%
Differential Sensitivity
50%
Prescription Stimulants
50%
High-speed Diagnostics
50%
Prescription Stimulant Misuse
33%
Information Platform
25%
National Testing
25%
Spat
25%
Laboratory Workflow
25%
Proficiency Testing
25%
Testing Capacity
25%
Assay Validation
25%
Automated Data Analysis
25%
Assay Standardization
25%
Software Instrumentation
25%
Screening Program
25%
COVID-19 Screening
25%
Manual Intervention
25%
Clinical Grade
25%
Personnel Protective Equipment
25%
Continuous Quality Control
25%
Medical Use
16%
Saliva Collection
12%
Decentralized Testing
12%
High-throughput Platform
12%
National Public Health Institute
12%
Medical Misuse
8%
Ever Use
8%
Non-medical Reasons
8%
Cross-sectional Online Survey
8%
Drug Prevention
8%
Attention Disorder
8%
Community Practitioners
8%
Lifetime Prevalence
8%
Prevention Campaign
8%
Student Community
8%
Symptom Status
6%
Load Sensitivity
6%
Less Invasive
6%
Test Sensitivity
6%
Alternative Sampling
6%
Nasopharyngeal Specimens
6%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Real-Time Polymerase Chain Reaction
50%
Diagnostic Accuracy
50%
COVID-19
50%
Molecular Diagnosis
50%
Laboratory Test
25%
Diseases
25%
Screening
25%
Infection
25%
Pathogen
25%
Public Health
25%
Diagnosis
25%
Coronavirinae
25%
